POAI

Predictive Oncology Inc. POAI

POAI
Predictive Oncology Inc. MYNZ
Mainz Biomed B.V. BNGO
Bionano Genomics, Inc. VYNE
VYNE Therapeutics Inc. KTTA
Pasithea Therapeutics Corp. GBS
GBS Inc. TCRT
Alaunos Therapeutics, Inc. HSCS
HeartSciences Inc. CYCN
Cyclerion Therapeutics, Inc. AIM
AIM ImmunoTech Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode POAI MYNZ BNGO VYNE KTTA GBS TCRT HSCS CYCN AIM
6M -54.41 % -16.08 % -50.00 % -34.15 % 55.08 % -33.36 % -17.02 % -37.23 % -50.85 % -84.58 %
YTD -56.88 % -72.09 % -89.56 % -82.40 % -60.41 % -60.24 % 80.71 % -36.90 % -55.93 % -93.55 %
1Y -44.70 % -74.84 % -86.70 % -75.48 % -56.55 % -32.40 % 76.24 % -30.99 % -50.85 % -92.53 %
3Y -94.57 % -99.59 % -99.84 % -80.27 % -92.27 % -95.71 % -95.64 % -97.38 % -88.11 % -95.70 %
5Y -97.06 % -99.70 % -99.52 % -99.56 % -98.37 % -95.71 % -99.15 % -98.61 % -97.78 % -99.35 %
10Y -100.00 % -99.70 % -97.40 % -99.97 % -98.37 % -95.71 % -99.71 % -98.61 % -99.42 % -99.97 %
From the beginning -100.00 % -99.70 % -97.40 % -99.97 % -98.37 % -95.71 % -99.85 % -98.61 % -99.42 % -84.51 %

Dividend